The primary antibodies used were anti- VEGF-A (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- VEGFR1 (Cell Signaling Technology, Berkeley, CA, USA), anti- pVEGFR1 (Cell Signaling Technology, Berkeley, CA, USA), anti- AKT (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- pAKT (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- ERK (Cell Signaling Technology, Berkeley, CA, USA), anti- pERK (Cell SignalingT echnology, Berkeley, CA, USA), anti- p38 (Cell Signaling Technology, Berkeley, CA, USA), anti- p-p38 (Cell Signaling Technology, Berkeley, CA, USA), anti- eNOS (Proteintech, Chicago, IL, USA), anti- p-eNOS (Proteintech, Chicago, IL, USA), anti- CHOP (Cell Signaling Technology, Berkeley, CA, USA) and anti- -actin (Cell Signaling Technology, Berkeley, CA, USA)
BouwmanIIKollenBJvan der MeerKNijmanRJvan der HeideWK.Are lower urinary tract symptoms in men associated with cardiovascular diseases in a primary care population: a registry study
These are on top of the well-known skin care darlings like retinol, vitamin C, and salicylic acid
Ferroptosis and acetaminophen hepatotoxicity: Are we going down another rabbit hole
Both adjustments follow the same 12-week frequency schedule as the standard 3.2 mg KLOW dose